Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01231932 · ClinicalTrials.gov registry record
Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors
A clinical trial, sponsored by National Institute of Nursing Research (NINR).
- Terminated
- Registry status
- 163
- Enrollment target
NCT01231932 is a clinical trial that was terminated before completion, run by National Institute of Nursing Research (NINR). The registered enrollment target is 163 participants.
The verdict
NCT01231932 was terminated before completion, sponsored by National Institute of Nursing Research (NINR).
- TERMINATED
- Registry status
- 163 participants
- Enrollment target
Study Summary
Background: \- Fatigue is a common side effect of cancer and its treatment. Up to 96% of patients with cancer have fatigue. The cause of fatigue in people with cancer or those receiving treatment is poorly understood, making fatigue hard to treat. More research is necessary to understand why cancer patients experience fatigue. Previous research has shown that fatigue may be caused by a number of factors, including problems with the immune system response of the body while undergoing cancer treatment. The researchers of this study are trying to understand how the immune system and other chemicals of the body change while a person receives cancer treatment and how these changes play a role in causing fatigue. The researchers are also interested in how a person s quality of life is affected by fatigue. Objectives: \- To study fatigue in individuals who have cancer, are receiving cancer treatment, or have completed cancer treatment. Eligibility: * Individuals at least 18 years of age. * Receiving cancer treatment, OR completed primary treatment for cancer (e.g., cancer survivors), OR on active surveillance for localized cancer. Design: * This study involves an initial screening visit and up to three outpatient visits. * Participants will be screened with a medical history review (can be done virtually) and blood tests. A physical exam might also occur. * Participants undergoing cancer treatment that has a clear completion date, will have the following visits: * Before the start of treatment. * At the end of treatment. * At least 3 months after treatment ends. * Participants not receiving treatment, are cancer survivors, or undergoing cancer treatment that does not have a clear completion date, will have up to 3 visits: * Before the start of treatment or whenever you begin the study. * At least 3 months after your first visit. * At least 3 months after your second visit. * At each study visit, participants will complete the following tasks (some of t
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2011-02-04 |
| Est. Completion | 2025-04-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01231932
The ClinicalTrials.gov registry entry for NCT01231932 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Nursing Research (NINR), which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01231932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01231932 about?
NCT01231932 is a clinical study titled "Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors". Background: \- Fatigue is a common side effect of cancer and its treatment. Up to 96% of patients with cancer have fatigue. The cause of fatigue in people with cancer or those receiving treatment is poorly understood, making fatigue hard to treat. More research is necessary to understand why cancer...
What is the current status of trial NCT01231932?
This trial is currently terminated. The enrollment target is 163 participants. The study started on 2011-02-04. Estimated completion is 2025-04-16.
Who is sponsoring clinical trial NCT01231932?
This trial is sponsored by National Institute of Nursing Research (NINR), which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.